Good morning from Geneva.
If generative AI is going to be more than hype and hallucinations, the trillion-dollar pharma industry is where the magic may happen. And no one is more ready to make it happen than Sanofi CEO Paul Hudson.
Last week, Hudson proudly announced his company’s new partnership with OpenAI and Formation Bio, a biotech. In the first-of-its-kind partnership, Sanofi will give OpenAI access to its databases, hoping that generative AI can be the key to quicker and more effective drug development.
“Large-language models give us this insane opportunity to suppress, summarize, and create,” Hudson told me on the phone from Paris. “It can help us get to a level in R&D where you can design a [drug candidate’s] molecular structure or identify appropriate patients that a drug will benefit.”
Is this then the generative AI application the world has been waiting for?
“It costs us 3-4 billion [dollars] to develop a drug, and 80% fail in phase 1 clinical trials,” Hudson said. “I’d like to know in advance what will fail. [Our collaboration with OpenAI] is putting that money to work in other projects with a higher probability of success.”
Neither is the promise of AI in health care years or decades away, Hudson believes.
The first results of Sanofi’s OpenAI collaboration should be in by the end of 2024 and will most likely take the form of AI-generated first drafts of FDA documents. The results of the more profound work on research and development and drug discovery should follow soon after. “I want to see early signs next year,” he said.
Still, whether this new partnership will indeed one day unlock billions of dollars in savings or new blockbuster revenues remains to be seen. But Hudson did stress that it is this kind of tie-up between industry and AI innovators on cutting-edge and high-value projects is the real deal.
“We knew we needed to not just buy a license [for the internal use of OpenAI],” he said. There’s a certain vanity to such licensing deals, which essentially create a “powerful Google.” “You can feel good about [OpenAI licensing]. You can write a press release.” This partnership, however, “is less about that, and more about operationalizing LLMs.”
More news below
Peter Vanham
[email protected]
Follow on LinkedIn
TOP NEWS
Shareholders get a say in AI
Meta shareholders will vote Wednesday on whether the social media company should release an annual report detailing the risk of “facilitating misinformation and disinformation disseminated or generated” via AI. While the vote is unlikely to succeed (due to Meta’s dual-class stock that gives founders outsized voting power), it could send a message to management about key AI concerns if the proposal wins over shareholders. Fortune
Thinx loses its way
The fall of Thinx, the once-buzzy women’s underwear startup, is now a lesson for other brands hoping to avoid the pitfalls of selling out to a larger company. Former employees complain that Thinx’s new owner, the conglomerate Kimberly-Clark, which bought the brand for around $230 million, of failing to capitalize on its irreverent and transparent voice. Another gripe: a hands-off approach when Thinx battled a forever-chemicals lawsuit that jilted loyal customers. Fortune
Evergrande fallout
The collapse of Chinese real estate developer Evergrande is now hurting the reputation of its former auditor PricewaterhouseCoopers. PwC clients are reportedly changing to other firms as regulators scrutinize the Big Four auditing company. Authorities have accused Evergrande of inflating its revenue by almost $80 billion, in spite of the developer’s results getting PwC’s stamp of approval. Financial Times
AROUND THE WATERCOOLER
Gen Z really are the hardest to work with—even managers of their own generation say they’re difficult. Instead, bosses plan to hire more of their millennial counterparts by Orianna Rosa Royle
Amazon, Walmart, and Target finally realize their colossal pricing mistake—now they’re slashing costs to win back customers by Sasha Rogelberg
Book excerpt: ‘I’m 100% sure that bringing children into this world is still the right thing to do’ by Tom Steyer
Elon Musk is recruiting xAI staffers who are ‘without regard to popularity or political correctness’ a day after raising $6 billion from investors by Christiaan Hetzner
Toyota’s bet on hybrids was mocked, then vindicated. Now it’s trying to repeat the trick with an unlikely bet on the combustion engine by Marco Quiroz-Gutierrez
This edition of CEO Daily was curated by Nicholas Gordon.